当前位置：公众访问 >页面
简体中文 / English
1.Screening
1.1.Management for Progress
1.1.1.1.1.1、Character of name

LYG

1.1.1.1.1.2、test number

54

1.1.1.1.1.3、Entering time

2019/11/13 (YYYY/MM/DD)

1.2.Inclusion Criteria

aspirin related small intestinal mucosal injury
/
agree with the research plan
/
sign the informed consent
1.3.Exclusion Criteria

contradications of MCCE
/
GI tract obstruction,or pregnant woman,or abdominal operation history, or can not undertake abdominal operation
/
taking drugs that influencing the test during the past one month
/
taking other antiplatelet or anticoagulant drugs
/
GI tumor or IBD diagnosed by MCCE
/
allergy to aspirin, lactobacillus, PEG,or high polymer material
2.Baseline
2.1.Management of the progress
2.2.General information
2.2.2.2.2.1、Basic information

2.2.2.2.2.2、Past history

高血压、高脂血症

2.2.2.2.2.3、GSRS

2

2.3.First result of MCCE
2.2.3.2.3.1、Gastric injury Lanza score

2

2.2.3.2.3.2、Time of gastric examination

25 min

2.2.3.2.3.3、Other result of stomach

无

2.2.3.2.3.4、Small intestine injury score

2

2.2.3.2.3.5、Time of small intestine examination

240 min

2.2.3.2.3.6、Other result of small intestine

无

2.2.3.2.3.7、Whether or not to complete the smll intestine test

yes
2.2.3.2.3.8、Time of passing out the capsule

hour

2.2.3.2.3.9、Side effect of bowel preparation

无

2.2.3.2.3.10、Side effect of MCCE

无

2.4.Result of blood tests
2.2.4.2.4.1、Inflammatory cytokines

2.2.4.2.4.2、Others

2.5.Result of stool microbiota test
2.2.5.2.5.1、Phylum level

Actinobacteria 15.7 Ascomycota 0 Bacteroidetes 62.12 Euryarchaeota 0 Firmicutes 21.32 Fusobacteria 0 Proteobacteria 0.81 Synergistetes 0 Verrucomicrobia 0.05 Viruses_noname 0 others 0

2.2.5.2.5.2、Class level

Actinobacteria 16.48 Bacilli 3.65 Bacteroidia 58.42 Betaproteobacteria 0 Clostridia 19.89 Deltaproteobacteria 0 Erysipelotrichia 0.03 Gammaproteobacteria 1 Negativicutes 0.47 Verrucomicrobiae 0.05 others 0

2.2.5.2.5.3、Order level

Bacteroidales 62.01 Bifidobacteriales 8.74 Burkholderiales 0 Clostridiales 22.97 Coriobacteriales 1.65 Desulfovibrionales 0 Enterobacteriales 1.07 Lactobacillales 2.88 Selenomonadales 0.5 Verrucomicrobiales 0.06 others 0.13

2.2.5.2.5.4、Family level

Bacteroidaceae 67.37 Bifidobacteriaceae 6.8 Enterobacteriaceae 0.84 Eubacteriaceae 1.01 Lachnospiraceae 3.56 Porphyromonadaceae 0 Prevotellaceae 0.02 Rikenellaceae 0 Ruminococcaceae 15.94 Veillonellaceae 0.45 others 4

2.2.5.2.5.5、Genus level

Alistipes 0 Bacteroides 67.82 Bifidobacterium 8.09 Escherichia 0.77 Eubacterium 1.13 Faecalibacterium 12.45 Parabacteroides 0 Prevotella 0.01 Roseburia 2.61 Subdoligranulum 0.59 others 6.53

2.2.5.2.5.6、Specie level

Bacteroides_coprocola 0 Bacteroides_dorei 0.01 Bacteroides_ovatus 0 Bacteroides_plebeius 0 Bacteroides_stercoris 0 Bacteroides_vulgatus 46.95 Escherichia_coli 0.74 Eubacterium_rectale 0.59 Faecalibacterium_prausnitzii 12.34 Prevotella_copri 0.01 others 39.36

2.2.5.2.5.7、Functional gene

2.2.5.2.5.8、Functional pathway

2.2.5.2.5.9、Data of stool microbiata

2.6.Others

3.In the process of the treatment
3.1.Whether or not to enter the test and group

Lactobacillus group
3.2.Primary symptom

3.3.Using other drugs

3.4.Side effect

无

3.5.Others

4.At the end of the treatment
4.1.Whether or not to exit

Complete the research
4.2.GSRS after treatmrnt

4.3.Sceond result of MCCE
4.4.3.4.3.1、Gastric injury Lanza score

2

4.4.3.4.3.2、Time of gastric examination

25 min

4.4.3.4.3.3、Other result of stomach

无

4.4.3.4.3.4、Small intestine injury score

2

4.4.3.4.3.5、Time of small intestine examination

450 min

4.4.3.4.3.6、Other result of small intestine

无

4.4.3.4.3.7、Whether or not to complete the smll intestine test

yes
4.4.3.4.3.8、Time of passing out the capsule

hour

4.4.3.4.3.9、Side effect of bowel preparation
4.4.3.4.3.10、Side effect of MCCE

无

4.4.Result of blood tests after treatment
4.4.4.4.4.1、Inflammatory cytokines

4.4.4.4.4.2、Others

4.5.Result of stool microbiota test after treatment
4.4.5.4.5.1、Phylum level

Actinobacteria 9.51 Ascomycota 0 Bacteroidetes 70.57 Euryarchaeota 0 Firmicutes 16.19 Fusobacteria 0 Proteobacteria 3.52 Synergistetes 0 Verrucomicrobia 0.2 Viruses_noname 0 others 0

4.4.5.4.5.2、Class level

Actinobacteria 10.05 Bacilli 0.57 Bacteroidia 66.81 Betaproteobacteria 0 Clostridia 17.79 Deltaproteobacteria 0 Erysipelotrichia 0 Gammaproteobacteria 4.37 Negativicutes 0.18 Verrucomicrobiae 0.23 others 0

4.4.5.4.5.3、Order level

Bacteroidales 68.77 Bifidobacteriales 4.67 Burkholderiales 0 Clostridiales 19.92 Coriobacteriales 1.64 Desulfovibrionales 0 Enterobacteriales 2.89 Lactobacillales 0.43 Selenomonadales 0.19 Verrucomicrobiales 0.24 others 1.26

4.4.5.4.5.4、Family level

Bacteroidaceae 74.2 Bifidobacteriaceae 3.61 Enterobacteriaceae 2.24 Eubacteriaceae 1.07 Lachnospiraceae 6.24 Porphyromonadaceae 0 Prevotellaceae 0 Rikenellaceae 0 Ruminococcaceae 9.15 Veillonellaceae 0.17 others 3.31

4.4.5.4.5.5、Genus level

Alistipes 0 Bacteroides 73.63 Bifidobacterium 4.23 Escherichia 1.08 Eubacterium 1.18 Faecalibacterium 5.88 Parabacteroides 0 Prevotella 0 Roseburia 4.76 Subdoligranulum 0.54 others 8.68

4.4.5.4.5.6、Specie level

Bacteroides_coprocola 0 Bacteroides_dorei 0 Bacteroides_ovatus 0.01 Bacteroides_plebeius 0 Bacteroides_stercoris 0.01 Bacteroides_vulgatus 56.55 Escherichia_coli 1.12 Eubacterium_rectale 0.02 Faecalibacterium_prausnitzii 5.95 Prevotella_copri 0 others 36.34

4.4.5.4.5.7、Functional gene

4.4.5.4.5.8、Functional pathway

4.4.5.4.5.9、Data of stool microbiata

4.6.Others after treatment

5.Logging data
5.1.Keyboarder

孙亚梅

5.2.Time of logging

2020/07/30 (YYYY/MM/DD)

6.Speciman management system
7.Data management system
8.ADR/ADE management system
9.Madicine management system
10.Research team
10.1.Researchers
11.Design, Methods
11.1.Calculation of sample size

提示：推荐使用chrome浏览器 并且在宽屏显示分辨率下使用系统。

Copyright(c) (2010-2013) .All rights reserved.临床试验公共管理平台 版权所有